首页> 美国卫生研究院文献>Gut >Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.
【2h】

Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.

机译:抗生素相关性结肠炎的复发:万古霉素治疗期间艰难梭菌的内源性持久性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study reports 24 patients with antibiotic associated colitis due to Clostridium difficile. Fifteen patients were treated with vancomycin due to the severity of the colitis and in eight of these a clinical relapse of the colitis occurred after vancomycin therapy was stopped. Bacteriological investigations of these patients indicated that C difficile was able to persist in stool samples during vancomycin therapy in the absence of detectable cytotoxin. This was in contrast with the seven patients successfully treated with vancomycin without relapse, and those not treated with vancomycin where both stool cultures and cytotoxin assays became negative. These results suggest that patients being treated with vancomycin for antibiotic associated colitis due to C difficile should have stool cultures done during and after treatment. Persistence of the organism in the absence of detectable cytotoxin may identify those patients who relapse and lead to either recommencement of vancomycin or alternative therapeutic approaches.
机译:这项研究报告了24例由于艰难梭菌引起的抗生素相关性结肠炎。由于结肠炎的严重程度,有15例患者接受了万古霉素治疗,其中有8例在万古霉素治疗停止后发生了结肠炎的临床复发。这些患者的细菌学研究表明,万古霉素治疗期间,在没有可检测到的细胞毒素的情况下,艰难梭菌能够在粪便样本中持续存在。这与七名成功接受万古霉素治疗且未复发的患者和未接受万古霉素治疗的患者的粪便培养和细胞毒素检测均呈阴性形成对比。这些结果表明,接受万古霉素治疗的因艰难梭菌引起的抗生素相关性结肠炎的患者应在治疗期间和之后进行粪便培养。在没有可检测到的细胞毒素的情况下生物体的持久性可以识别出那些复发并导致万古霉素重新出现或其他治疗方法的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号